Clinical Trials in Los Angeles

Showing 15001-15020 of 16,901 trials

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

NCT01907282

Preventing psychotic disorders such as schizophrenia and associated functional disability could relieve an enormous burden of personal and family suffering and economic losses to society. This project aims to conduct a pilot randomized trial to determine the efficacy of a family-focused treatment in comparison with treatment-as-usual in enhancing functional outcomes, stabilizing symptoms, and preventing or delaying the onset of full psychosis in transitional age youth with prodromal symptoms. The results of this study will be crucial for the development of cost-effective, evidence-based psychosocial approaches to psychosis prevention and thus will have major implications for public health.

Psychosis

University of California, Los Angeles129 participantsStarted Jan 2010

Los Angeles, California, United States • San Diego, California, United States • New Haven, Connecticut, United States +5 more locations

COMPLETEDPhase 3< 1 mile

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

NCT00623428

This study will evaluate the efficacy and safety of peginterferon alfa-2a 40KD + ribavirin combination therapy given for 24 weeks versus 48 weeks in patients with chronic hepatitis C, genotype 2/3.

Hepatitis C, Chronic

Hoffmann-La Roche235 participantsStarted Jun 2008

Birmingham, Alabama, United States • La Jolla, California, United States • Lancaster, California, United States +98 more locations

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

A Study of Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

Find Trials by Condition in Los Angeles

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis

A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Dose Escalation Study of MLN4924 in Adults With Melanoma

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma

Japanese Bridging Study Conducted in the United States

Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal Women

Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails